{
  "id": 12683595,
  "title": "Ultragenyx sells PRV for $210M and still has another to monetize",
  "url": "https://urgent.news/2026/10/07/ultragenyx-sells-prv-for-210m-and-still-has-another-to-monetize",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-10-07T18:24:16.000Z",
  "source": {
    "name": "Endpoints News",
    "slug": "endpoints-news",
    "url": "https://endpoints.news/ultragenyx-sells-prv-for-210m-and-still-has-another-to-monetize/"
  },
  "original_language": "en",
  "account": null,
  "summary": "Ultragenyx Pharmaceutical is selling a priority review voucher to an undisclosed buyer for $210 million, marking one of the richest sales of the speedy-approval tool so far this year. The California ...",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}